Martin Muddu, Edrisa Mutebi, SSinabulya Isaac, Samuel Kizito, Frank Mulindwa, Kiiza Mondo Charles
Department of Medicine, Makerere University College of Health Sciences, Mulago Hospital Complex, Uganda.
Clinical Epidemiology Unit, Makerere University College of Health Sciences, Uganda.
J Obes Weight Loss Medicat. 2018;4(1). doi: 10.23937/2572-4010.1510021. Epub 2018 Aug 23.
Microalbuminuria is an early marker of nephropathy, cardiovascular diseases and severe ocular morbidity in adults with diabetes mellitus. This subclinical condition is associated with high morbidity and mortality. Microalbuminuria precedes the development of overt diabetic nephropathy by 10-14 years. At this stage, one can reverse diabetic nephropathy or prevent its progression. Unfortunately, tests to detect microalbuminuria in diabetics are not routinely done in Uganda. This study sought to determine the prevalence and factors associated with microalbuminuria among newly diagnosed diabetic patients in the National Referral Hospital in Uganda.
In this cross-sectional study conducted between June 2014 and January 2015, we recruited 175 newly diagnosed adult diabetic patients. Information on patients' socio-demographics, biophysical profile, blood pressure measurement, biochemical testing and echocardiographic findings was obtained for all the participants using a pre-tested questionnaire. Microalbuminuria was defined as Albumin to Creatinine Ratio (ACR) between 30 and 299 mg/g. Bivariate and multivariate logistic regression analyses were used to investigate the association of several factors with microalbuminuria.
Of the 175 patients recruited, males were 90 (51.4%) and the mean age was 46 ± 15 years. Majority of patients had type 2 DM 140 (80.0%) and the rest had type 1 DM 35 (20.0%). The mean HbA1C was 13.9 ± 5.3%. Mean duration of diabetes was 2 months. Prevalence of microalbuminuria was 47.4% (95% CI: 40.0%-54.9%) among all the patients that were assessed in the study. The independent factor associated with microalbuminuria was pregnancy (OR7.74[95% CI: 1.01-76.47] P = 0.050) while mild and moderate physical activity at work were inversely associated with microalbuminuria respectively (OR0.08[95% CI: 0.01-0.95] P = 0.046) and (OR0.07[95% CI: 0.01-0.77] P = 0.030).
Prevalence of microalbuminuria was high in this patient population of newly diagnosed diabetes mellitus. Pregnancy was positively associated with significant microalbuminuria while physical activity at work was inversely associated with microalbuminuria. Early detection and management of microalbuminuria in asymptomatic individuals may help in preventing deterioration in renal function and development of overt diabetic nephropathy and progression to ESRD.
微量白蛋白尿是糖尿病成年患者肾病、心血管疾病和严重眼部疾病的早期标志物。这种亚临床状态与高发病率和死亡率相关。微量白蛋白尿比显性糖尿病肾病的发生早10 - 14年。在此阶段,可以逆转糖尿病肾病或阻止其进展。不幸的是,乌干达并未对糖尿病患者进行常规的微量白蛋白尿检测。本研究旨在确定乌干达国家转诊医院新诊断糖尿病患者中微量白蛋白尿的患病率及其相关因素。
在2014年6月至2015年1月进行的这项横断面研究中,我们招募了175名新诊断的成年糖尿病患者。使用预先测试的问卷获取了所有参与者关于社会人口统计学、生物物理特征、血压测量、生化检测和超声心动图检查结果的信息。微量白蛋白尿定义为白蛋白与肌酐比值(ACR)在30至299 mg/g之间。采用双变量和多变量逻辑回归分析来研究多个因素与微量白蛋白尿的关联。
在招募的175名患者中,男性90名(51.4%),平均年龄为46±15岁。大多数患者为2型糖尿病,共140例(80.0%),其余35例(20.0%)为1型糖尿病。平均糖化血红蛋白(HbA1C)为13.9±5.3%。糖尿病平均病程为2个月。在本研究评估的所有患者中,微量白蛋白尿的患病率为47.4%(95%置信区间:40.0% - 54.9%)。与微量白蛋白尿相关的独立因素是妊娠(比值比7.74[95%置信区间:1.01 - 76.47],P = 0.050),而工作时轻度和中度体力活动分别与微量白蛋白尿呈负相关(比值比0.08[95%置信区间:0.01 - 0.95],P = 0.046)和(比值比0.07[95%置信区间:0.01 - 0.77],P = 0.030)。
在这个新诊断糖尿病患者群体中,微量白蛋白尿的患病率很高。妊娠与显著微量白蛋白尿呈正相关,而工作时的体力活动与微量白蛋白尿呈负相关。对无症状个体早期检测和管理微量白蛋白尿可能有助于预防肾功能恶化、显性糖尿病肾病的发生以及进展至终末期肾病(ESRD)。